{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:39:08Z","timestamp":1792931948896,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100015060","name":"Nagasaki University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Med Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>A wide inequality exists between high- and low-income countries in the outcome of paediatric acute lymphoblastic leukaemia (ALL). At a tertiary-level hospital in Tanzania, multidimensional approaches have been taken to improve cancer care for children. This study aimed to update the outcomes of paediatric ALL at Muhimbili National Hospital (MNH), Tanzania from 2016 to 2020.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We performed a retrospective chart review of children who were treated with modified UKALL2003 protocol at MNH from January 1, 2016 to December 31, 2020. We used the Cox proportional hazards model to estimate the effect of each prognostic factor on event-free survival (EFS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We identified 202 patients who had confirmatory diagnoses of ALL and initiated treatment at MNH. Fifty-two patients (26%, 52\/202) died (<jats:italic>n<\/jats:italic>\u2009=\u200947) or abandoned treatment (<jats:italic>n<\/jats:italic>\u2009=\u20095) before the end of remission induction. The main causes of death during this period were infections and bleeding complications. The median EFS was 9\u00a0months and 2-year EFS was 36%. Oedema, non-early rapid responder, and non-remission were associated with short EFS in the multivariable analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The number of new paediatric ALL admissions at MNH has doubled in the past decade. The prevention of early deaths is critical to improve the long-term survival of paediatric ALL in Tanzania.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41182-025-00760-2","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T03:22:37Z","timestamp":1748316157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical characteristics and outcomes of paediatric acute lymphoblastic leukaemia in a tertiary hospital in Tanzania: a single-centre observational study"],"prefix":"10.1186","volume":"53","author":[{"given":"Koki","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koga","family":"Luhulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magreth","family":"Msoffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chambega","family":"Chambega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salama","family":"Mahawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Primus","family":"Ewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godlove","family":"Sandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Msirikale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchius","family":"Philbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Kabona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Chirande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana Jacqueline","family":"Nakiddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Scanlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Maringe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Rachet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadija","family":"Mwamtemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"issue":"6","key":"760_CR1","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","volume":"18","author":"E Steliarova-Foucher","year":"2017","unstructured":"Steliarova-Foucher E, Colombet M, Ries LAG, et al. International incidence of childhood cancer, 2001\u201310: a population-based registry study. Lancet Oncol. 2017;18(6):719\u201331. https:\/\/doi.org\/10.1016\/S1470-2045(17)30186-9.","journal-title":"Lancet Oncol"},{"issue":"2","key":"760_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3322\/caac.21219","volume":"64","author":"E Ward","year":"2014","unstructured":"Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83\u2013103. https:\/\/doi.org\/10.3322\/caac.21219.","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"760_CR3","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","volume":"30","author":"SP Hunger","year":"2012","unstructured":"Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children\u2019s oncology group. J Clin Oncol. 2012;30(14):1663\u20139. https:\/\/doi.org\/10.1200\/JCO.2011.37.8018.","journal-title":"J Clin Oncol"},{"issue":"10125","key":"760_CR4","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani C, Matsuda T, Carlo VD, et al. Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023\u201375. https:\/\/doi.org\/10.1016\/S0140-6736(17)33326-3.","journal-title":"Lancet"},{"key":"760_CR5","unstructured":"World Health Organization. WHO global initiative for childhood cancer: an overview. https:\/\/www.who.int\/docs\/default-source\/documents\/health-topics\/cancer\/who-childhood-cancer-overview-booklet.pdf. Accessed August 28, 2024."},{"issue":"Suppl","key":"760_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/pbc.26879","volume":"64","author":"SC Howard","year":"2017","unstructured":"Howard SC, Davidson A, Luna-Fineman S, et al. A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: the pediatric oncology in developing countries (PODC) committee of the international pediatric oncology society (SIOP). Pediatr Blood Cancer. 2017;64(Suppl):5. https:\/\/doi.org\/10.1002\/pbc.26879.","journal-title":"Pediatr Blood Cancer"},{"issue":"20","key":"760_CR7","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1001\/jama.291.20.2471","volume":"291","author":"SC Howard","year":"2004","unstructured":"Howard SC, Pedrosa M, Lins M, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA. 2004;291(20):2471\u20135. https:\/\/doi.org\/10.1001\/jama.291.20.2471.","journal-title":"JAMA"},{"issue":"12","key":"760_CR8","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1002\/pbc.24576","volume":"60","author":"E Kersten","year":"2013","unstructured":"Kersten E, Scanlan P, Dubois SG, Matthay KK. Current treatment and outcome for childhood acute leukemia in Tanzania. Pediatr Blood Cancer. 2013;60(12):2047\u201353. https:\/\/doi.org\/10.1002\/pbc.24576.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"760_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1470-2045(12)70600-9","volume":"14","author":"A Vora","year":"2013","unstructured":"Vora A, Goulden N, Wade R, et al. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomized controlled trial. Lancet Oncol. 2013;14(3):199\u2013209. https:\/\/doi.org\/10.1016\/S1470-2045(12)70600-9.","journal-title":"Lancet Oncol"},{"issue":"16","key":"760_CR10","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/NEJMra1400972","volume":"373","author":"SP Hunger","year":"2015","unstructured":"Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373(16):1541\u201352. https:\/\/doi.org\/10.1056\/NEJMra1400972.","journal-title":"N Engl J Med"},{"issue":"12","key":"760_CR11","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1038\/s41375-022-01714-x","volume":"36","author":"M Thastrup","year":"2022","unstructured":"Thastrup M, Duguid A, Mirian C, Schmiegelow K, Halsey C. Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutions. Leukemia. 2022;36(12):2751\u201368. https:\/\/doi.org\/10.1038\/s41375-022-01714-x.","journal-title":"Leukemia"},{"issue":"17","key":"760_CR12","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1002\/cncr.33609","volume":"127","author":"HTK Nguyen","year":"2021","unstructured":"Nguyen HTK, Terao MA, Green DM, Pui CH, Inaba H. Testicular involvement of acute lymphoblastic leukemia in children and adolescents: diagnosis, biology, and management. Cancer. 2021;127(17):3067\u201381. https:\/\/doi.org\/10.1002\/cncr.33609.","journal-title":"Cancer"},{"key":"760_CR13","unstructured":"World Health Organization. Immunization United Republic of Tanzania 2023 country profile. https:\/\/cdn.who.int\/media\/docs\/default-source\/country-profiles\/immunization\/2023-country-profiles\/immunization_tza_2023.pdf?sfvrsn=9fbc3b6d_3&download=true. Accessed November 20, 2023."},{"key":"760_CR14","unstructured":"The United Republic of Tanzania, Ministry of Health and Social Welfare\u2014Tanzania Mainland. Expanded programme on immunization 2010\u20132015 comprehensive multi year plan. https:\/\/bidinitiative.org\/wp-content\/uploads\/1405554135TanzaniaComprehensivemultiyearplanfor20102015Year2011.pdf. Accessed November 20, 2023."},{"issue":"2","key":"760_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1179\/146532810X12703902516167","volume":"30","author":"J Metodi","year":"2010","unstructured":"Metodi J, Aboud S, Mpembeni R, Munubhi E. Immunity to hepatitis B vaccine in Tanzanian under-5 children. Ann Trop Paediatr. 2010;30(2):129\u201336. https:\/\/doi.org\/10.1179\/146532810X12703902516167.","journal-title":"Ann Trop Paediatr"},{"issue":"10003","key":"760_CR16","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(15)61412-X.","journal-title":"Lancet"},{"key":"760_CR17","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016\u20132021. Towards ending viral hepatitis. https:\/\/www.who.int\/publications\/i\/item\/WHO-HIV-2016.06. Accessed April 17, 2025."},{"key":"760_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4239646","author":"SB Kilonzo","year":"2018","unstructured":"Kilonzo SB, Gunda DW, Mpondo BCT, Bakshi FA, Jaka H. Hepatitis B virus infection in Tanzania: current status and challenges. J Trop Med. 2018. https:\/\/doi.org\/10.1155\/2018\/4239646.","journal-title":"J Trop Med"},{"issue":"10","key":"760_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29768","volume":"69","author":"TS Severance","year":"2022","unstructured":"Severance TS, Njuguna F, Olbara G, et al. An evaluation of the disparities affecting the underdiagnosis of pediatric cancer in Western Kenya. Pediatr Blood Cancer. 2022;69(10): e29768. https:\/\/doi.org\/10.1002\/pbc.29768.","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"760_CR20","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S1470-2045(23)00318-2","volume":"24","author":"BS Ehrlich","year":"2023","unstructured":"Ehrlich BS, McNeil MJ, Pham LTD, et al. Treatment-related mortality in children with cancer in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Oncol. 2023;24(9):967\u201377. https:\/\/doi.org\/10.1016\/S1470-2045(23)00318-2.","journal-title":"Lancet Oncol"},{"issue":"5","key":"760_CR21","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/pbc.24855","volume":"61","author":"AE Seif","year":"2014","unstructured":"Seif AE, Fisher BT, Li Y, et al. Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemia. Pediatr Blood Cancer. 2014;61(5):846\u201352. https:\/\/doi.org\/10.1002\/pbc.24855.","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"760_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29366","volume":"68","author":"G Olbara","year":"2021","unstructured":"Olbara G, van der Wijk T, Njuguna F, et al. Childhood acute lymphoblastic leukemia treatment in an academic hospital in Kenya: treatment outcomes and health-care providers\u2019 perspectives. Pediatr Blood Cancer. 2021;68(12): e29366. https:\/\/doi.org\/10.1002\/pbc.29366.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"760_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","volume":"14","author":"M Smith","year":"1996","unstructured":"Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol. 1996;14(1):18\u201324. https:\/\/doi.org\/10.1200\/JCO.1996.14.1.18.","journal-title":"J Clin Oncol"},{"issue":"8","key":"760_CR24","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41375-024-02277-9","volume":"38","author":"P Rujkijyanont","year":"2024","unstructured":"Rujkijyanont P, Inaba H. Diagnostic and treatment strategies for pediatric acute lymphoblastic leukemia in low- and middle-income countries. Leukemia. 2024;38(8):1649\u201362. https:\/\/doi.org\/10.1038\/s41375-024-02277-9.","journal-title":"Leukemia"},{"issue":"4","key":"760_CR25","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1182\/blood-2011-11-389569","volume":"120","author":"CD Josephson","year":"2012","unstructured":"Josephson CD, Granger S, Assmann SF, et al. Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia. Blood. 2012;120(4):748\u201360. https:\/\/doi.org\/10.1182\/blood-2011-11-389569.","journal-title":"Blood"},{"issue":"17","key":"760_CR26","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1200\/JCO.19.03024","volume":"38","author":"S Gupta","year":"2020","unstructured":"Gupta S, Wang C, Raetz EA, et al. Impact of asparaginase discontinuation on outcome in childhood acute lymphoblastic leukemia: a report from the children\u2019s oncology group. J Clin Oncol. 2020;38(17):1897\u2013905. https:\/\/doi.org\/10.1200\/JCO.19.03024.","journal-title":"J Clin Oncol"},{"issue":"17","key":"760_CR27","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1200\/JCO.2011.38.9924","volume":"30","author":"S Bhatia","year":"2012","unstructured":"Bhatia S, Landier W, Shangguan M, et al. Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children\u2019s oncology group. J Clin Oncol. 2012;30(17):2094\u2013101. https:\/\/doi.org\/10.1200\/JCO.2011.38.9924.","journal-title":"J Clin Oncol"},{"issue":"12","key":"760_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29899","volume":"69","author":"E Chakumatha","year":"2022","unstructured":"Chakumatha E, Khofi H, Landman L, et al. Towards zero percent treatment abandonment of patients with common and curable childhood cancer types in Blantyre, Malawi. Pediatr Blood Cancer. 2022;69(12): e29899. https:\/\/doi.org\/10.1002\/pbc.29899.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"760_CR29","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1182\/blood.V94.4.1209","volume":"94","author":"M D\u00f6rdelmann","year":"1999","unstructured":"D\u00f6rdelmann M, Reiter A, Borkhardt A, et al. Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood. 1999;94(4):1209\u201317.","journal-title":"Blood"},{"issue":"6","key":"760_CR30","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/(sici)1097-0142(19990315)85:6<1395::aid-cncr25>3.0.co;2-2","volume":"85","author":"LB Silverman","year":"1999","unstructured":"Silverman LB, Gelber RD, Young ML, Dalton VK, Barr RD, Sallan SE. Induction failure in acute lymphoblastic leukemia of childhood. Cancer. 1999;85(6):1395\u2013404. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19990315)85:6%3c1395::aid-cncr25%3e3.0.co;2-2.","journal-title":"Cancer"},{"issue":"17","key":"760_CR31","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1182\/blood.2019004215","volume":"135","author":"F Pedrosa","year":"2020","unstructured":"Pedrosa F, Coustan-Smith E, Zhou Y, et al. Reduced-dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study. Blood. 2020;135(17):1458\u201366. https:\/\/doi.org\/10.1182\/blood.2019004215.","journal-title":"Blood"},{"issue":"3","key":"760_CR32","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1200\/JCO.1999.17.3.818","volume":"17","author":"CH Pui","year":"1999","unstructured":"Pui CH, Boyett JM, Relling MV, et al. Sex differences in prognosis for children with acute lymphoblastic leukemia. J Clin Oncol. 1999;17(3):818\u201324. https:\/\/doi.org\/10.1200\/JCO.1999.17.3.818.","journal-title":"J Clin Oncol"},{"issue":"3","key":"760_CR33","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/pbc.25829","volume":"63","author":"C Cohler","year":"2016","unstructured":"Cohler C, Jumanne S, Kaijage J, DuBois SG, Scanlan P, Matthay KK. Evaluation and outcome of central nervous system involvement in pediatric acute lymphoblastic leukemia in Dar es Salaam. Tanzania Pediatr Blood Cancer. 2016;63(3):458\u201364. https:\/\/doi.org\/10.1002\/pbc.25829.","journal-title":"Tanzania Pediatr Blood Cancer"}],"container-title":["Tropical Medicine and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00760-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41182-025-00760-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00760-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T10:18:35Z","timestamp":1750673915000},"score":1,"resource":{"primary":{"URL":"https:\/\/tropmedhealth.biomedcentral.com\/articles\/10.1186\/s41182-025-00760-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["760"],"URL":"https:\/\/doi.org\/10.1186\/s41182-025-00760-2","relation":{},"ISSN":["1349-4147"],"issn-type":[{"value":"1349-4147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The layout of Tables 2 and 4 has been adjusted.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data collection and analyses were conducted with the permission of MNH. The ethical review board of MNH waived the need for informed consent, based on the condition that the anonymity of each patient was assured. The study was approved by the ethical committee of the School of Tropical Medicine and Global Health, Nagasaki University (NU_TMGH_2022_214_1), MNH (MNH\/IRB\/I\/2022\/058), National Institute for Medical Research (NIMR\/HQ\/R.8a\/Vol.IX\/4049), and the Tanzania Commission for Science and Technology (2023\u2013057-NA-2023\u20130303).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}